| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |